Amneal Pharmaceuticals: Q1 Earnings Insights

12:43pm, Monday, 11'th May 2020
Shares of Amneal Pharmaceuticals (NYSE:AMRX) moved higher by 13% in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share rose 42.86% year over year to $0.20, w
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the "Company") announced its results today for the first quarter ended March 31, 2020.
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the “Company”) announced its results today for the first quarter ended March 31, 2020. “We are proud of how
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
Amneal (AMRX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The epinephrine autoinjector market is poised to grow by 762.51 mn during 2020-2024, according to Technavio
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
This week in patent filings, PTAB filings are back up, with four post grant reviews and 37 inter partes reviews, while there were 83 district court complaints; the district court numbers skew high bec
'Millions' of doses of Oxford University's vaccine could be available as early as September with human trials, consisting of 6,000 participants, set to begin in May, it has been reported
Amneal Pharmaceuticals Inc (NYSE:AMRX) – Stock analysts at SVB Leerink upped their FY2021 earnings per share (EPS) estimates for Amneal Pharmaceuticals in a research note issued on Thursday, April 2
Amneal to Report First Quarter 2020 Results on May 11, 2020
Drugmakers across the globe are rushing to develop a treatment or vaccine for the fast-spreading coronavirus that has wreaked havoc across the globe, killing over 191,000 people and ravaging financial
In a statement, the FDA is cautioning against the use of malaria meds chloroquine and hydroxychloroquine outside of the hospital setting for the treatment of COVID-19 due to the risk of adverse heart
Finnish drugmaker Orion raised its 2020 operating profit forecast on Friday, helped by strong demand for drugs including a sedative and a respiratory treatment due to coronavirus pandemic.
Finnish drugmaker Orion raised its 2020 operating profit forecast on Friday, helped by strong demand for drugs including a sedative and a respiratory treatment due to coronavirus pandemic.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE